Feeds › Insider trades
Insider trades
Open-market buys and sells by officers, directors and 10% owners, from SEC Form 4. Usually filed within two business days.
About this data
- What it is
- When a company's officers, directors or owners of more than 10% buy or sell its stock, they must report the trade to the SEC on Form 4. This feed shows purchases and sales on the open market; stock grants, option exercises and shares withheld for tax are left out.
- Who files it
- The insider, usually through the company, within two business days of the trade.
- How current
- We collect new filings throughout the day on SEC business days.
- Worth knowing
- Sales are often routine: insiders sell to diversify, to pay taxes, or under a 10b5-1 plan set up months in advance. A purchase with their own money is less common, which is why many investors pay closer attention to it.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
Open-market trades per day, last 30 days
Purchases Sales
By trade date. Insiders have two business days to file, so the most recent days fill in later.
Latest open-market insider trades
Showing: ticker FMNB
| Traded | Insider | Company | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Sep 21, 2026 | Gina A. Richardson Director | FMNB Farmers National Banc Corp. | Buy | 1,430 | $15.35 | $22.0K Buy | Form 4 ↗ |
| Aug 6, 2026 | Mark J. Wenick SEVP/Chief Wealth Mgt Officer | FMNB Farmers National Banc Corp. | Sale | 5,000 | $15.97 | $79.8K Sale | Form 4 ↗ |
| Jun 22, 2026 | Michael C. Voinovich Director | FMNB Farmers National Banc Corp. | Sale | 23,309 | $14.21 | $331.2K Sale | Form 4 ↗ |
| Mar 26, 2026 | Nicholas D. Varischetti Director | FMNB Farmers National Banc Corp. | Buy | 2,000 | $12.90 | $25.8K Buy | Form 4 ↗ |
| Mar 26, 2026 | Nicholas D. Varischetti Director | FMNB Farmers National Banc Corp. | Buy | 73,000 | $12.97 | $946.8K Buy | Form 4 ↗ |
| Mar 19, 2026 | Gina A. Richardson Director | FMNB Farmers National Banc Corp. | Buy | 441 | $12.43 | $5,482 Buy | Form 4 ↗ |
| Mar 5, 2026 | Gina A. Richardson Director | FMNB Farmers National Banc Corp. | Buy | 1,231 | $12.91 | $15.9K Buy | Form 4 ↗ |
| Mar 3, 2026 | Edward Muransky Director | FMNB Farmers National Banc Corp. | Buy | 40,000 | $12.74 | $509.6K Buy | Form 4 ↗ |
| Feb 2, 2026 | Amber B. Wallace SEVP/Chief Retail & Marketing | FMNB Farmers National Banc Corp. | Buy | 15 | $13.02 | $195 Buy | Form 4 ↗ |
| Jan 2, 2026 | Amber B. Wallace SEVP/Chief Retail & Marketing | FMNB Farmers National Banc Corp. | Buy | 14 | $13.35 | $187 Buy | Form 4 ↗ |
| Oct 30, 2025 | Gina A. Richardson Director | FMNB Farmers National Banc Corp. | Buy | 1,833 | $12.99 | $23.8K Buy | Form 4 ↗ |
| Oct 24, 2025 | Edward Muransky Director | FMNB Farmers National Banc Corp. | Buy | 73,500 | $13.59 | $998.9K Buy | Form 4 ↗ |
| Mar 5, 2025 | Gina A. Richardson Director | FMNB Farmers National Banc Corp. | Buy | 2,334 | $13.75 | $32.1K Buy | Form 4 ↗ |
| Jan 31, 2025 | Ralph D. Macali Director | FMNB Farmers National Banc Corp. | Sale | 14,300 | $14.00 | $200.2K Sale | Form 4 ↗ |
| Jan 2, 2025 | Joseph W. Sabat VP/Chief Accounting Officer | FMNB Farmers National Banc Corp. | Buy | 88 | $14.26 | $1,255 Buy | Form 4 ↗ |
15 items, most recent first (up to 50). Every row links to its original filing. Updated Nov 15, 2026, 6:27 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances